dba

Publications on Biomarkers Used in COVID-19 Research Email not displaying correctly?
View it in your browser.


Neuropilin-1 and GDF-15

Additional Immune Markers Identified for COVID-19


In addition to Myriad RBM’s InflammationMAP for COVID-19 research and therapy development, several more soluble protein biomarkers in our menu of 300+ biomarkers have recently been discovered to be extremely important in SARS-CoV-2  infection and pathologies.

Neuropilin-1
Two high profile papers published in Science1,2 demonstrate that Neuropilin-1 is a cell surface factor in addition to ACE2 for viral entry and infection.  Blood levels of Neuropilin-1 may shed light on the importance of this factor.

GDF-15
A study in Circulation3 revealed that high baseline concentrations of GDF-15, a TGF-beta superfamily member with a role in inflammatory and apoptotic pathways, were associated with SARS-CoV-2 viremia and hypoxemia (both p<0.001) and was prognostically superior to established cardiovascular and inflammatory biomarkers.

IFN-a, IFN-ß, & IFN-?
Previous Science publications have also listed IFN-a, IFN-ß, & IFN-? ultrasensitive immunoassays as important markers for viral pneumonia, including COVID-19. You read can more in our blog post.

 

Publications 

  1. Neuropilin-1 is a host factor for SARS-CoV-2 infection. (2020) Daly JL, et al. Science. DOI:10.1126/science.abd3072
  2. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. (2020) Cantuti-Castelvetri L, et al. Science. DOI: 10.1126/science.abd2985
  3. Growth differentiation factor-15 provides prognostic information superior to established cardiovascular and inflammatory biomarkers in unselected patients hospitalized with COVID-19. (2020) Myhre PL, et al. Circulation. DOI: 10.1161/CIRCULATIONAHA.120.050360.

VIEW IMMUNE MONITORING SOLUTIONS FOR COVID-19 RESEARCH 

 

Richiedi un'offerta

DBA-ITALIA Srl
Via Umbria 10
20054 Segrate (Milano)

Tel. +39 02-26922300
Fax +39 02-26926058
Fax +39 02-26923535




If you no longer wish to receive these announcements click here